GHRP-6
Growth Hormone Releasing Peptide-6 · Hexapeptide GHS
GHRP-6 is a synthetic growth hormone secretagogue that stimulates the pituitary gland to release growth hormone. It was one of the first GHRPs developed and works by binding to the ghrelin receptor (GHS-R1a). Unlike direct HGH injections, GHRP-6 enhances the body's natural GH production while keeping negative feedback mechanisms balanced. It is known for its potent appetite-stimulating effects.
Overview
GHRP-6 is a synthetic growth hormone secretagogue that stimulates the pituitary gland to release growth hormone. It was one of the first GHRPs developed and works by binding to the ghrelin receptor (GHS-R1a). Unlike direct HGH injections, GHRP-6 enhances the body's natural GH production while keeping negative feedback mechanisms balanced. It is known for its potent appetite-stimulating effects.
GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R1a), the same receptor activated by ghrelin. This initiates a signaling cascade in the hypothalamus and pituitary gland, triggering a rapid pulse of natural GH secretion. The released GH then signals the liver to secrete IGF-1, which promotes muscle growth and fat metabolism. GHRP-6 also stimulates ghrelin release, causing significant appetite increase.
Research indications
What the compound has been studied for, grouped by body system. Effect size is the reported magnitude where it was measured — not a recommendation.
Potent stimulation of endogenous growth hormone release through ghrelin receptor activation.
Indirectly increases IGF-1 levels through enhanced GH secretion from the pituitary.
Enhanced muscle protein synthesis through elevated growth hormone and IGF-1 levels.
Significant increase in hunger through ghrelin pathway activation, beneficial for those needing to gain weight.
Faster recovery from exercise and improved tissue repair.
Research indicates protective effects on cardiac tissue independent of GH release.
Systemic cytoprotective effects with anti-inflammatory properties observed in liver and other organs.
Attenuation of reactive oxygen species and preservation of antioxidant defenses.
A large effect in a weak study and a small effect in a strong one are different things. Effect size is never evidence of use in people.
- Class
- Synthetic hexapeptide
- Chain length
- 6 residues
- Molecular weight
- 873 Da
- Half-life
- ~38 min
- Typical dose
- 100-300 mcg per injection
- Frequency
- 2-3 times daily (morning, post-workout optional, before bed)
- Cycle length
- 8-12 weeks
- Storage
- Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 28 days
Molecular data
- Type
- Synthetic hexapeptide
- Molecular weight
- 873 Da
- Chain length
- 6 residues
- Half-life
- 38 min
Dosing reference
Doses reported in the literature and by suppliers. These are a record of what has been used in research — reference, never instruction.
| Context | Route | Amount | Frequency |
|---|---|---|---|
| GH optimization | SubQ | 100 mcg | 2-3x daily |
| Enhanced results | SubQ | 200-300 mcg | 2-3x daily |
| With GHRH (synergy) | SubQ (combined) | 100 mcg each | 2-3x daily |
| Appetite/bulking | SubQ | 100-200 mcg | Before meals |
Interactions
GHRH + GHRP combination produces synergistic GH release significantly greater than either alone.
Classic stack; GHRH amplifies GHRP-6's effects on growth hormone release.
Similar mechanism; GHRP-2 is more potent with less appetite stimulation.
Both are GHRPs; Ipamorelin has fewer side effects but is less potent.
No known negative interactions; often combined for recovery protocols.
Simultaneous administration may increase GH response, but carb consumption blunts GH release.
Quality checklist
- ✓White to off-white lyophilized powder
- ✓Clear solution after reconstitution
- ✓Intact vacuum seal on vial
- !Slight clumping that dissolves with gentle swirling
- ×Discolored or yellow powder
- ×Cloudy solution after reconstitution
- ×Particles or precipitates in solution
What to expect
Safety
- Intense hunger/increased appetite (most notable side effect)
- Water retention
- Tingling or numbness in extremities
- Tiredness or lethargy after injection
- Mild headache
- Severe or persistent headaches
- Unusual swelling in hands or feet
- Signs of carpal tunnel syndrome
- Allergic reactions
- Hypoglycemia symptoms
- Active cancer or history of cancer
- Pregnancy or breastfeeding
- Pituitary disorders
- Diabetes (use with caution)
- WADA prohibited for competitive athletes
FAQ
Why does GHRP-6 cause intense hunger while GHRP-2 doesn't?
GHRP-6 potently stimulates ghrelin release (the 'hunger hormone') in addition to GH stimulation, whereas GHRP-2 is more selective for GH with minimal ghrelin elevation. This difference in receptor selectivity makes GHRP-6 cause profound appetite increase 15-20 minutes post-injection, while GHRP-2 is significantly less orexigenic.
Is GHRP-6 better for bulking because of the appetite increase?
Yes, GHRP-6's appetite stimulation can be beneficial for bulking phases where consuming excess calories is the goal. The intense hunger makes eating surplus calories easier. For cutting phases, GHRP-2 is preferable to avoid fighting appetite stimulation, making peptide selection cycle-dependent.
How soon after GHRP-6 injection will I feel hungry?
Hunger typically begins within 15-20 minutes of subcutaneous GHRP-6 injection and peaks around 30-45 minutes post-injection. It can be quite intense, making meal timing important. Planning to eat 20-30 minutes after injection aligns appetite peak with eating windows.
Can I stack GHRP-6 with CJC-1295 for maximum GH release?
Yes, GHRP-6 stacked with CJC-1295 creates powerful synergy—GHRH + GHRP combination releases significantly more GH than either alone. This is the classic 'stack' for maximizing growth hormone, though it requires careful dosing to avoid excessive IGF-1 elevation and managing combined side effects like water retention and joint stress.